References

1. Griesinger W. (1861). Pathologie und Therapie psychischer Krankheiten, 2nd edn. Krabbe, Stuttgart.

2. Kraepelin E. (1893). Psychiatrie. Ein Lehrbuch für Studierende und Aerzte, 4th edn. Barth, Leipzig.

3. Bleuler E. (1911). Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg G. (ed.) Handbuch der Psychiatrie. Deuticke, Leipzig, pp. 1-420.

4. Hafner H. (1995). Was ist Schizophrenie. In: Hafner H. (ed.) Was ist Schizophrenie? Fischer, Stuttgart, pp. 1-44.

5. Maier W., Rietschel M., Linz M., Falkai P. (2002). Genetics of schizophrenia and related disorders. In: Hafner H. (ed.) Risk and Protective Factors in Schizophrenia. Springer-Verlag, Berlin, pp. 9-28.

6. Sullivan S.H. (1927). The onset of schizophrenia. Am. J. Psychiatry, 6, 105-134.

7. Cameron D.E. (1938). Early diagnosis of schizophrenia by the general practitioner. N. Engl. J. Med., 218, 221-224.

8. Cameron D.E. (1938). Early schizophrenia. Am. J. Psychiatry, 95, 567-578.

9. Hafner H., Maurer K., Loffler W., Riecher-Rossler A. (1993). The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry, 162, 80-86.

10. Hafner H., an der Heiden W., Loffler W., Maurer K., Hambrecht M. (1998). Beginn und Frühverlauf schizophrener Erkrankungen. In: Klosterkeitter J. (ed.) Frühdiagnostik und Frühbehandlung psychischer Störungen. Bayer-ZNS-Symposium XIII. Springer-Verlag, Berlin, pp. 1-28.

11. Gross G. (1969). Prodrome und Vorpostensyndrome schizophrener Erkrankungen. In: Huber G. (ed.) Schizophrenie und Zyklothymie. Thieme, Stuttgart, pp. 177-187.

12. Lindelius R. (1970). A study of schizophrenia: a clinical, prognostic and family investigation. Acta Psychiatr. Scand., 216 (Suppl.), 1-125.

13. Huber G., Gross G., Schüttler R. (1979). Schizophrenie. Eine Verlaufs- und sozialpsychiatrische Langzeitstudie. Springer-Verlag, Berlin.

14. Loebel A.D., Lieberman J.A., Alvir J.M.J., Mayerhoff D.I., Geisler S.H., Szymanski S.R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. Am. J. Psychiatry, 149, 1183-1188.

15. Beiser M., Erickson D., Flemming J.A.E., Iacono W.G. (1993). Establishing the onset of psychotic illness. Am. J. Psychiatry, 150, 1349-1354.

16. McGorry P.D., Edwards J., Mihalopoulos C., Harrigan S.M., Jackson H.J. (1996). EPPIC: an evolving system of early detection and optimal management. Schizophr. Bull, 22, 305-326.

17. Lewine R.J. (1980). Sex differences in age of symptom onset and first hospitalization in schizophrenia. Am. J. Orthopsychiatry, 50, 316-322.

18. Hafner H., Maurer K., Loffler W., Bustamante S., an der Heiden W., Riecher-Rossler A., Nowotny B. (1995). Onset and early course of schizophrenia. In: Hafner H., Gattaz W.F. (eds) Search for the Causes of Schizophrenia, vol. III. Springer-Verlag, Berlin, pp. 43-66.

19. Johannessen J.O., Larsen T.K., McGlashan T. (1999). Duration of untreated psychosis: an important target for intervention in schizophrenia? Nord. J. Psychiatry, 53, 275-283.

20. Ho B.C., Alicata D., Ward J., Moser D.J., O'Leary D.S., Arndt S., Andreasen N.C. (2003). Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am. J. Psychiatry, 160, 142-148.

21. Conrad K. (1958). Die beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns. Thieme-Verlag, Stuttgart.

22. Docherty J.P., van Kammen D.P., Siris S.G., Marder S.R. (1978). Stages of onset of schizophrenic psychosis. Am. J. Psychiatry, 135, 420-426.

23. Hafner H., Maurer K., Loffler W., an der Heiden W., Hambrecht M., Schultze-Lutter F. Modeling the early course of schizophrenia. Schizophr. Bull., 29, 325-340.

24. Hafner H., Riecher A., Maurer K., Meissner S., Schmidtke A., Fatkenheuer B., Loffler W., an der Heiden W. (1990). Ein Instrument zur retrospektiven Einschatzung des Erkrankungsbeginns bei Schizophrenie (Instrument for the Retrospective Assessment of the Onset of Schizophrenia - "IRAOS") Entwicklung und Ergebnisse. Z. Klin. Psychol., 19, 230-255.

25. Hafner H., Riecher-Rossler A., Hambrecht M., Maurer K., Meissner S., Schmidtke A., Fatkenheuer B., Loffler W., an der Heiden W. (1992). IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr. Res., 6, 209-223.

26. Hafner H., Riecher-Rossler A., Fatkenheuer B., Maurer K., Meissner S., Loffler W. (1992). Interview for the Retrospective Assessment of the Onset of Schizophrenia (IRAOS) (trans. G. Patton). Published by H. Hafner.

27. Hafner H., Loffler W., Maurer K., Riecher-Rossler A., Stein A. (1999). IRAOS. Interview für die retrospektive Erfassung des Erkrankungsbeginns und -Verlaufs bei Schizophrenie und anderen Psychosen. Hans Huber Verlag, Bern.

28. Hafner H., Loffler W., Maurer K., Riecher-Rossler A., Stein A. (2003). IRAOS -Interview for the Retrospective Assessment of the Onset and Course of Schizophrenia and Other Psychoses. Hogrefe & Huber, Gottingen.

29. Hambrecht M., Hafner H. (1993) ''Trema, Apophanie, Apokalypse'' - Ist Conrads Phasenmodell empirisch begründbar? Fortschr. Neurol. Psychiatr., 61, 418-423.

30. Foulds G.A. (1976). The Hierarchical Nature of Personal Illness. Academic Press, London.

31. de Jong A., Giel R., Lindeboom E.G., Slooff C.J., Wiersma D. (1984). Foulds' hierarchical model of psychiatric illness in a Dutch cohort: a re-evaluation. Psychol. Med., 14, 647-654.

32. Biehl H., Maurer K., Jung E., Krumm B., Schubart C. (1987). Zum "natürlichen Verlauf'' schizophrener Erkrankungen - Begriff und Beispiele zum beobachteten Verhalten in einer prospektiven Studie. Nervenheilkunde, 6, 153-163.

33. Faris R.E., Dunham W. (1939). Mental Disorders in Urban Areas. An Ecological Study of Schizophrenia and Other Psychoses. University of Chicago Press, Chicago, IL.

34. Dauncey K., Giggs J., Baker K., Harrison G. (1993). Schizophrenia in Nottingham: lifelong residential mobility of a cohort. Br. J. Psychiatry, 163, 613-619.

35. Kohn M. (1969). Class and Conformity: A Study of Values. Dorsey Press, Home-wood, IL.

36. Eaton W.W. (1999). Evidence for universality and uniformity of schizophrenia around the world: assessment and implications. In: Gattaz W.F., Hafner H. (eds) Search for the Causes of Schizophrenia, vol. IV: Balance of the Century. Steinkopff, Darmstadt; Springer-Verlag, Heidelberg, pp. 21-33.

37. Rabinowitz J., Reichenberg A., Weiser M., Mark M., Kaplan Z., Davidson M. (2000). Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital. Br. J. Psychiatry, 177, 26-32.

38. Van Os J., Verdoux H., Maurice-Tison S., Gay B., Liraud F., Salamon R., Bourgeois M. (1999). Self-reported psychosis-like symptoms and the continuum of psychosis. Soc. Psychiatry Psychiatr. Epidemiol., 34, 459-463.

39. Hanssen M.S.S., Bak M., Bijl R., Vollebergh W., van Os J. (2002). Is prediction of psychosis in the general population feasible? Eur. Psychiatry, 17 (Suppl. 1), 74.

40. Verdoux H., van Os J. (2002). Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res., 54, 59-65.

41. Yung A.R., McGorry P.D. (1996). The prodromal phase of first-episode psychosis: past and current conceptualisations. Schizophr. Bull., 22, 353-370.

42. Johnstone E.C., Crow T.J., Johnson A.L., McMillan J.F. (1986). The Northwick Park study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission. Br. J. Psychiatry, 148, 115-120.

43. Norman R.M., Malla A.K. (2001). Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol. Med., 31, 381-400.

44. Birchwood M., McMillan J.F. (1993). Early intervention in schizophrenia. Aust. N. Zeal. J. Psychiatry, 27, 374-378.

45. Linszen D., Lenior M., de Haan L., Dingemans P., Gersons B. (1998). Early intervention, untreated psychosis and the course of early schizophrenia. Br. J. Psychiatry, 172 (Suppl. 33), 84-89.

46. McEvoy J.P., Schooler N.R., Wilson W.H. (1991). Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacol. Bull., 27, 97-101.

47. Haas G.L., Gattatt L.S., Sweeney J.A. (1998). Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J. Psychiatr. Res., 32, 151-159.

48. Szymanski S.R., Cannon T.D., Gallacher F., Erwin R.J., Gur R.E. (1996). Course of treatment response in first-episode and chronic schizophrenia. Am. J. Psychiatry, 153, 519-525.

49. Bottlender R., Strauss A., Moller H.-J. (2000). Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophr. Res., 44, 145-150.

50. McGorry P.D., Edwards J. (1997). Early Psychosis Training Pack. Gardiner-Caldwell Communications, Victoria Mill, Australia.

51. Larsen T.K., Johannessen J.O., Opjordsmoen S. (1998). First-episode schizophrenia with long duration of untreated psychosis. Pathways to care. Br. J. Psychiatry, 172, 45-52.

52. Helgason L. (1990). Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr. Scand., 81, 231-235.

53. Stirling J., Tantam D., Thomas P., Newby D., Montague L., Ring N., Rowe S. (1991). Expressed emotion and early onset schizophrenia: a one-year follow-up. Psychol. Med., 21, 675-685.

54. Stirling J., Tantam D., Thomas P., Newby D., Montague L., Ring N., Rowe S. (1993). Expressed emotion and schizophrenia: the ontogeny of EE during an 18-month follow-up. Psychol. Med., 23, 771-778.

55. Addington J., Addington D. (1998). Effect of substance misuse in early psychosis. Br. J. Psychiatry, 172 (Suppl. 33), 134-136.

56. Addington D., Addington J., Patten S. (1998). Depression in people with firstepisode schizophrenia. Br. J. Psychiatry, 172, 90-92.

57. Koreen A.R., Siris S.G., Chakos M., Alvir J., Mayerhoff D., Lieberman J. (1993). Depression in first episode schizophrenia. Am. J. Psychiatry, 150, 1643-1648.

58. Strakowski S.M., Keck P.E. Jr, McElroy S.L., Lonczak H.S., West S.A. (1995). Chronology of comorbid and principal syndromes in first-episode psychosis. Compr. Psychiatry, 36, 106-112.

59. Johnstone E.C., McMillan J.F., Frith C.D., Benn D.K., Crow T.J. (1990). Further investigation of the predictors of outcome following first schizophrenic episodes. Br. J. Psychiatry, 157, 182-189.

60. Larsen T.K., McGlashan T.H., Moe L.C. (1996). First-episode schizophrenia: I. Early course parameters. Schizophr. Bull., 22, 241-256.

61. Humphreys M.S., Johnstone E.C., McMillan J.F., Taylor P.J. (1992). Dangerous behaviour preceding first admissions for schizophrenia. Br. J. Psychiatry, 161, 501-505.

62. Hafner H., Maurer K., Loffler W., an der Heiden W., Konnecke R., Hambrecht M. (2002). The early course of schizophrenia. In: Hafner H. (ed.) Risk and Protective Factors in Schizophrenia. Steinkopff, Darmstadt, pp. 207-228.

63. Craig T.J., Bromet E.J., Fennig S., Tanenberg-Karant M., Lavelle J., Galambos N. (2000). Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am. J. Psychiatry, 157, 60-66.

64. Robinson D.G., Woerner M.G., Alvir J., Ma J., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., Bilder R., et al. (1999). Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry, 156, 544-549.

65. Robinson D.G., Woemer M.G., Alvir J., Ma J., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., et al. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry, 56, 241-247.

66. Ho B.C., Andreasen N.C., Flaum M., Nopoulos P., Miller D. (2000). Untreated initial psychosis: its relation to quality of life and symptom remission in firstepisode schizophrenia. Am. J. Psychiatry, 157, 808-815.

67. Altamura A.C., Bassetti R., Sassella F., Salvadori D., Mundo E. (2001). Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophr. Res., 52, 29-36.

68. Malla A.K., Norman R.M., Manchanda R., Ahmed M.R., Scholten D., Harricharan R., Cortese L., Takhar J. (2002). One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr. Res., 54, 231-242.

69. Joyce E., Hutton S., Mutsatsa S., Gibbins H., Webb E., Paul S., Robbins T., Barnes T. (2002). Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis. Br. J. Psychiatry, 181 (Suppl. 43), 38-44.

70. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., Germano D., Bravin J., Adlard S., McDonald T., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry, 59, 921-928.

71. Hoff A.L., Sakuma M., Razi K., Heydebrand G., Csernansky J.G., DeLisi L.E. (2000). Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am. J. Psychiatry, 157, 1824-1828.

72. Barnes T.R., Hutton S.B., Chapman M.J., Mutsatsa S., Puri B.K., Joyce E.M. (2000). West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br. J. Psychiatry, 177, 207-211.

73. Harrigan S.M., McGorry P.D., Krstev H. (2003). Does treatment delay in firstepisode psychosis really matter? Psychol. Med., 33, 97-110.

74. Edwards J., McGorry P.D. (2002). Implementing Early Intervention in Psychosis. Dunitz, London.

75. Breier A., Schreiber J.L., Dyer J., Pickar D. (1991). National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch. Gen. Psychiatry, 48, 239-246.

76. Wyatt R.J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophr. Bull., 17, 325-351.

77. Wyatt R.J. (1995). Early intervention for schizophrenia: can the course of the illness be altered? Biol Psychiatry, 38, 1-3.

78. Lieberman J.A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K., Gilmore J. (2001). The early stages of schizophrenia: speculations on pathogenesis, pathophysiology and therapeutic approaches. Biol. Psychiatry, 50, 884-897.

79. Lieberman J.A., Tollefson G., Tohen M., Green A.I., Gur R.E., Kahn R., McEvoy J., Perkins D., Sharma T., Zipursky R., et al. (2003). Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am. J. Psychiatry, 160, 1396-1404.

80. McGlashan T.H., Johannessen J.O. (1996). Early detection and intervention with schizophrenia: a rationale. Schizophr. Bull., 22, 201-222.

81. Goldberg T.E., David A., Gold J.M. (2003). Neurocognitive deficits in schizophrenia. In: Hirsch S.R., Weinberger D.R. (eds) Schizophrenia, 2nd edn. Blackwell, Oxford, pp. 168-184.

82. Liddle P.F. (1987). Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol. Med., 17, 49-57.

83. Liddle P.F. (1987). The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br. J. Psychiatry, 151, 145-151.

84. Liddle P.F., Barnes T.R.E. (1990). Syndromes of chronic schizophrenia. Br. J. Psychiatry, 157, 558-561.

85. Loffler W., Hafner H. (1999). Dimensionen der schizophrenen Symptomatik. Nervenarzt, 70, 416-429.

86. Arndt S., Andreasen N.C., Flaum M., Miller D., Nopoulos P. (1995). A longitudinal study of symptom dimensions in schizophrenia - prediction and patterns of change. Arch. Gen. Psychiatry, 52, 352-360.

87. Salokangas R.K.R. (1997). Structure of schizophrenic symptomatology and its changes over time: prospective factor-analytical study. Acta Psychiatr. Scand., 95, 32-39.

88. DeLisi L.E., Sakuma M., Ge S., Kushner M. (1998). Association of brain structural change with the heterogeneous course of schizophrenia. Psychiatry Res., 84, 75-88.

89. Johnstone E.C., Russell K.D., Harrison L.K., Lawrie S.M. (2003). The Edinburgh High Risk Study: current status and future prospects. World Psychiatry, 2,45-49.

90. Lawrie S.M., Whalley H.C., Abukmeil S.S., Kestelman J.N., Donnelly L., Miller P., Best J.J.K., Owens D.G.C., Johnstone E.C. (2001). Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol. Psychiatry, 49, 811-823.

91. Fannon D., Chitnis X., Doku V., Tennakoon L., O'Ceallaigh S., Soni W., Sumich A., Lowe J., Santamaria M., Sharma T. (2000). Features of structural brain abnormality detected in first-episode psychosis. Am. J. Psychiatry, 157, 18291834.

92. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet, 361, 281-288.

93. Copolov D., Velakoulis D., McGorry P., Mallard C., Yung A., Rees S., Jackson G., Rehn A., Brewer W., Pantelis C. (2000). Neurobiological findings in early phase schizophrenia. Brain Res. Brain Res. Rev., 31, 157-165.

94. Malla A.K., Mittal C., Lee M., Scholten D.J., Assis L., Norman R.M. (2002). Computed tomography of the brain morphology of patients with first-episode schizophrenic psychosis. J. Psychiatry Neurosci., 27, 350-358.

95. Verdoux H., Maurice-Tison S., Gay B., Van Os J., Salamon R., Bourgeois M.L. (1998). A survey of delusional ideation in primary-care patients. Psychol. Med., 28, 127-134.

96. Lewis S., Tarrier N., Haddock G., Bentall R., Kinderman P., Kingdon D., Siddle R., Drake R., Everitt J., Leadley K. et al. (2002). Randomised, controlled trial of cognitive-behaviour therapy in early schizophrenia: acute phase outcomes. Br. J. Psychiatry, 181, 91-97.

97. Jackson J.H., McGorry P.D., McKenzie D. (1994). The reliability of DSM-III prodromal symptoms in first episode psychotic patients. Acta Psychiatr. Scand., 90, 375-378.

98. Janzarik W. (1968). Schizophrene Verläufe. Springer-Verlag, Berlin.

99. Hafner H., an der Heiden W. (2003). Course and outcome of schizophrenia. In: Hirsch S.R., Weinberger D.R. (eds) Schizophrenia, 2nd edn. Blackwell, Oxford, pp. 101-141.

100. Gaebel W., Frick U., Kopcke W., Linden M., Müller P., Müller-Spahn F., Pietzcker A., Tegeler J. (1993). Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse? Br. J. Psychiatry, 163 (Suppl. 21), 8-12.

101. Gaebel W., Frommann N. (2000). Long-term course in schizophrenia: concepts, methods and research strategies. Acta Psychiatr. Scand., 102, 49-53.

102. Birchwood M., Smith J., Macmillan F., Hogg B., Prasad R., Harvey C., Bering S. (1989). Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers. A preliminary investigation. Psychol. Med., 19, 649-656.

103. Carpenter W., Heinrichs D. (1983). Early intervention, time limited targeted pharmacotherapy for schizophrenia. Schizophr. Bull., 9, 533-542.

104. Hirsch S.R., Jolley A.G. (1989). The dysphoric syndrome in schizophrenia and its implications for relapse. Br. J. Psychiatry, 155 (Suppl. 5), 46-50.

105. Cutting J., Dunne F. (1989). Subjective experience of schizophrenia. Schizophr. Bull., 15, 217-231.

106. Jolley A.G., Hirsch S.R., McRink A., Manchanda R. (1989). Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. Br. Med. J., 298, 985-990.

107. Marder S.R., Wirshing W.C., Van Putten T., Mintz J., McKenzie J., Johnston-Cronk K., Lebell M., Liberman R.P. (1994). Fluphenazine vs. placebo supplementation for prodromal signs of relapse in schizophrenia. Arch. Gen. Psychiatry, 51, 280-287.

108. Herz M.I., Lamberti J.S., Mintz J., Scott R., O'Dell S.P., McCartan L., Nix G. (2000). A program for relapse prevention in schizophrenia: a controlled study. Arch. Gen. Psychiatry, 57, 277-283.

109. McGorry P.D. (1995). Psycho-education in first-episode psychosis: a therapeutic process. Psychiatry, 58, 329-344.

110. Herz M., Melville C. (1980). Relapse in schizophrenia. Am. J. Psychiatry, 137, 801-805.

111. Maurer K., Hafner H. (1995). Methodological aspects of onset assessment in schizophrenia. Schizophr. Res., 15, 265-276.

112. Klosterkotter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. (2001). Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry, 58, 158-164.

113. Biehl H., Maurer K., Schubart C., Krumm B., Jung E. (1986). Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics - results of a prospective 5-year follow-up study. Eur. Arch. Psychiatry Neurol. Sci., 236, 139-147.

114. Hafner H., Loffler W., Maurer K., Hambrecht M., an der Heiden W. (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr. Scand., 100, 105-118.

115. Dobmeier P., Bottlender R., Wittmann J., Groß A., Wegner U., Strauß A., Moller H.-U. (2000). Depressive Symptome bei schizophrenen Erkrankungen - Ergebnisse der Münchner 15-Jahres-Katamnese. In: Maier W., Engel R.R., Meiller H.-U. (eds) Methodik von Verlaufs- und Therapiestudien in Psychiatrie und Psychotherapie. Hogrefe, Gottingen, pp. 179-188.

116. Davidson L., McGlashan T.H. (1997). The varied outcomes of schizophrenia. Can. J. Psychiatry, 42, 34-43.

117. Dopfner M., Pluck J., Berner W., Fegert J.M., Huss M., Lenz K., Schmeck K., Lehmkuhl U., Poustka F., Lehmkuhl G. (1997). Psychische Auffalligkeiten von Kindern und Jugendlichen in Deutschland - Ergebnisse einer repräsentativen Studie: Methodik, Alters-, Geschlechts- und Beurteilereffekte. Z. Kinder Jugendpsychiatr. Psychother., 25, 218-233.

118. Choquet M., Ledoux S. (1994). Epidemiologie et adolescence. Confrontations psychiatriques, 27, 287-309.

119. Hafner H., Maurer K., Loffler W., an der Heiden W., Stein A., Konnecke R., Hambrecht M. (1999). Onset and prodromal phase as determinants of the course. In: Gattaz W.F., Hafner H. (eds) Search for the Causes of Schizophrenia, vol. IV: Balance of the Century. Steinkopff, Darmstandt; Springer-Verlag, Heidelberg, pp. 35-58.

120. Lewine R.R.J. (1988). Gender and schizophrenia. In: Nasrallah H.A. (ed.) Handbook of Schizophrenia, vol. 3. Elsevier, Amsterdam, pp. 379-397.

121. Angermeyer M.C., Kühn L. (1988). Gender differences in age at onset of schizophrenia. Eur. Arch. Psychiatry Neurol. Sci., 237, 351-364.

122. Hafner H., Riecher A., Maurer K., Loffler W., Munk-Jorgensen P., Stromgren E. (1989). How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol. Med., 19, 903-918.

123. Hafner H., Behrens S., Vry J. de, Gattaz W.F. (1992). An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res., 38, 125-134.

124. Loranger A.W. (1984). Sex difference in age of onset of schizophrenia. Arch. Gen. Psychiatry, 41, 157-161.

125. Seeman M.V., Lang M. (1990). The role of estrogens in schizophrenia gender differences. Schizophr. Bull., 16, 185-194.

126. Castle D.J., Wessely S., van Os J., Murray R.M. (1998). Psychosis in the Inner City: The Camberwell First Episode Study. Psychology Press, Hove, East Sussex.

127. Hambrecht M., Maurer K., Hafner H., Sartorius N. (1992). Transnational stability of gender differences in schizophrenia? Eur. Arch. Psychiatry Clin. Neurosci., 242, 6-12.

128. DeLisi L.E., Bass N., Boccio A., Shilds G., Morganti C., Vita A. (1994). Age of onset in familial schizophrenia. Arch. Gen. Psychiatry, 51, 334-335.

129. Albus M., Maier W. (1995). Lack of gender differences in age at onset in familial schizophrenia. Schizophr. Res., 18, 51-59.

130. Konnecke R., Hafner H., Maurer K., Loffler W., an der Heiden W. (2000). Main risk factors for schizophrenia: increased familial loading and pre- and perinatal complications antagonize the protective effect of oestrogen in women. Schizophr. Res., 44, 81-93.

131. Hafner H. (1987). Epidemiology of schizophrenia. In: Hafner H., Gattaz W.F., Janzarik W. (eds) Search for the Causes of Schizophrenia. Springer-Verlag, Berlin, pp. 47-74.

132. Hafner H., Behrens S., Vry J. de, Gattaz W.F. (1991). Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Eur. Arch. Psychiatry Clin. Neurosci., 241, 65-68.

133. Gattaz W.F., Behrens S., Vry J. de, Hafner H. (1992). Ostradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Ratten - ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie. Fortschr. Neurol. Psychiatr., 60, 8-16.

134. Stoiber G., Ungvari G.S. (eds) (2001). Catatonia: a new focus of research. Eur. Arch. Psychiatry Clin. Neurosci., 251 (Suppl. 1), 1-34.

135. Mimica N. (1996). Schizophrenia and its catatonic subtype instability during long-term follow-up. Schizophr. Res., 18, 101.

136. Hambrecht M., Hafner H. (1996). Substance abuse and the onset of schizophrenia. Biol. Psychiatry, 40, 1155-1163.

137. Bühler B., Hambrecht M., Loffler W., an der Heiden W., Hafner H. (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population-based first illness episodes. Schizophr. Res., 54, 243-251.

138. Malmberg A., Lewis G., David A., Allebeck P. (1998). Premorbid adjustment and personality in people with schizophrenia. Br. J. Psychiatry, 172, 308-313.

139. Davidson M., Reichenberg A., Rabinowitz J., Weiser M., Kaplan Z., Mark M. (1999). Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am. J. Psychiatry, 156, 1328-1335.

140. Johannessen J.O., Larsen T.K., Homeland M., Joa I., Mardal S., Kvebaek R., Friis S., Melle I., Opjordsmoen S., Simonsen E., et al. (2001). The TIPS Project. A systematized program to reduce duration of untreated psychosis in first episode psychosis. In: Miller T., Mednick S.A., McGlashan T.H., Libiger J., Johannessen J.O. (eds) Early Intervention in Psychotic Disorders. Kluwer, Dordrecht, pp. 151-166.

141. Sartorius N. (1998). Stigma: what can psychiatrists do about it? Lancet, 352, 1058-1059.

142. Sainsbury Centre for Mental Health (1998). Keys to Engagement: Review of Care for People with Severe Mental Illness who are Hard to Engage with Services. Sainsbury Centre Publications, London.

143. McGorry P.D. (2002). The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry, 1, 76-83.

144. Bell R.Q. (1992). Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry, 55, 370381.

145. Wolwer W., Buchkremer G., Hafner H., Klosterkotter J., Maier W., Moller H.-J., Gaebel W. (2003). German Research Network on Schizophrenia -bridging the gap between research and care. Eur. Arch. Psychiatry Clin. Neurosci., 253, 321-329.

146. Cornblatt B., Obuchowski M., Schnur D., O'Brien J.D. (1998). Hillside study of risk and early detection in schizophrenia. Br. J. Psychiatry, 172 (Suppl. 33), 26-32.

147. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., Patton S.G., Jackson H.J. (1998). Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br. J. Psychiatry, 172 (Suppl. 33), 14-20.

148. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. (2003). Psychosis prediction: 12 month follow-up of a high risk ("prodromal") group. Schizophr. Res., 60, 21-32.

149. Chapman J.P. (1966). The early symptoms of schizophrenia. Br. J. Psychiatry, 112, 225-251.

150. McGhie A., Chapman J. (1961). Disorders of attention and perception in early schizophrenia. Br. J. Med. Psychol., 34, 103-115.

151. Chapman L.J., Chapman P.J. (1980). Scales for rating psychotic or psychotic-like experiences as continua. Schizophr. Bull., 6, 476-489.

152. Chapman J.P., Chapman L.J. (1996). The psychometric assessment of schizophrenia proneness. In: Matthysse S., Levy D.L., Kagan J., Benes F.M. (eds) Psychopathology. The Evolving Science of Mental Disorder. Cambridge University Press, Cambridge, pp. 313-333.

153. Chapman L.J., Chapman J.P., Raulin M.L. (1976). Scales for physical and social anhedonia. J. Abnorm. Psychol., 85, 374-382.

154. Chapman L.J., Chapman J.P., Raulin M.L. (1978). Body-image aberration in schizophrenia. J. Abnorm. Psychol., 87, 399-407.

155. Gross G., Huber G., Klosterkotter J., Linz M. (1987). Bonner Skala für die Beurteilung von Basissymptomen (BSABS: Bonn Scale for the Assessment of Basic Symptoms). Springer-Verlag, Berlin.

156. Klosterkotter J., Hellmich M., Schultze-Lutter F. (2000). Ist die Diagnose schizophrener Störungen schon in der initialen Prodromalphase vor der psychotischen Erstmanifestation moglich? Fortschr. Neurol. Psychiatr., 68 (Sonderheft 1), 13-21.

157. Klosterkeitter M. (2002). Predicting the onset of schizophrenia. In: Hafner H. (ed.) Risk and Protective Factors in Schizophrenia. Steinkopff-Verlag, Darmstadt, pp. 193-206.

158. McGorry P.D., Copolov D.L., Singh B.S. (1990). Royal Park Multidiagnostic Instrument for Psychosis: Part I. Rationale and review. Schizophr. Bull., 16, 501-515.

159. McGorry P.D., Singh B.S., Copolov D.L., Kaplan I., Dossetor C.R., van Riel R.J. (1990). Royal Park Multidiagnostic Instrument for Psychosis: Part II. Development, reliability, and validity. Schizophr. Bull., 16, 518-536.

160. Yung A.R. (2000). The Comprehensive Assessment of At-Risk Mental States (CAARMS). University of Melbourne, Australia.

161. McGlashan T.H., Miller T.J., Woods S.W., Rosen J.L., Hoffman R.E., Davidson L. (2001). Structured Interview for Prodromal Syndromes. PRIME Research Clinic, Yale School of Medicine, New Haven, CT.

162. Miller T.J., McGlashan T.H., Woods S.W., Stein K., Driesen N., Corcoran C.M., Hoffman R., Davidson L. (1999). Symptom assessment in schizophrenic prodromal states. Psychiatr. Q., 70, 273-287.

163. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Marchovich P.J., Stein K., Woods S.W. (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry, 159, 863-865.

164. Hambrecht M., Hafner H. (1997). Sensitivity and specificity of relatives' reports on the early course of schizophrenia. Psychopathology, 30, 12-19.

165. Cohen R.Z., Seeman M.V., Gotowiec A., Kopala L. (1999). Earlier puberty as a predictor of later onset of schizophrenia in women. Am. J. Psychiatry, 156, 1059-1064.

166. Remschmidt H. (2002). Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry. J. Neural Transm, 109, 101-117.

167. Keith S.J., Matthews S.M. (1991). The diagnosis of schizophrenia: a review of onset and duration issues. Schizophr. Bull., 17, 51-67.

168. Jackson H.J., McGorry P.D., Dudgeon P. (1995). Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity. Compr. Psychiatry, 36, 241-250.

169. McGorry P.D., McFarlane C., Patton G.C., Bell R., Hibbert M.E., Jackson H.J., Bowes G. (1995). The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr. Scand., 92, 241-249.

170. McGorry P.D., McKenzie D., Jackson J.H., Waddell F., Curry C. (2000). Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia? Schizophr. Res., 42, 91-100.

171. Eaton W., Harrison G. (2001). Life chances, life planning and schizophrenia. A review and interpretation of research on social deprivation. Int. J. Ment. Health, 30, 58-81.

172 Hafner H., Maurer K., Ruhrmann S., Bechdolf A., Klosterkotter J., Wagner M., Maier W., Bottlender R., Moller H.-J., Gaebel W., et al. (2004) Early detection and secondary prevention of psychosis: facts and visions. Eur. Arch. Psychiatry Clin. Neurosci., 254, 117-128.

The ADHD Success Formula

The ADHD Success Formula

This is an audio and guide that will help you battle through ADHD and Accomplish Twice As Much In Half The Time. Learn more by download your very own copy today.

Get My Free Ebook


Post a comment